HomeCompareTHRD vs PLD

THRD vs PLD: Dividend Comparison 2026

THRD yields 37.17% · PLD yields 3.18%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 PLD wins by $6.31M in total portfolio value· pulled ahead in Year 7
10 years
THRD
THRD
● Live price
37.17%
Share price
$5.38
Annual div
$2.00
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$198.5K
Annual income
$31,557.09
Full THRD calculator →
PLD
PLD
● Live price
3.18%
Share price
$128.78
Annual div
$4.10
5Y div CAGR
74.4%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$6.50M
Annual income
$5,256,436.18
Full PLD calculator →

Portfolio growth — THRD vs PLD

📍 PLD pulled ahead of the other in Year 7

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodTHRDPLD
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, THRD + PLD cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
THRD pays
PLD pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

THRD
Annual income on $10K today (after 15% tax)
$3,159.85/yr
After 10yr DRIP, annual income (after tax)
$26,823.53/yr
PLD
Annual income on $10K today (after 15% tax)
$270.62/yr
After 10yr DRIP, annual income (after tax)
$4,467,970.75/yr
At 15% tax rate, PLD beats the other by $4,441,147.23/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of THRD + PLD for your $10,000?

THRD: 50%PLD: 50%
100% PLD50/50100% THRD
Portfolio after 10yr
$3.35M
Annual income
$2,643,996.64/yr
Blended yield
78.89%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on PLD right now

THRD
Analyst Ratings
1
Buy
4
Hold
Consensus: Hold
Price Target
$16.15
+200.2% upside vs current
Range: $3.60 — $23.00
Altman Z
19.7
Piotroski
1/9
PLD
Analyst Ratings
25
Buy
16
Hold
1
Sell
Consensus: Buy
Price Target
$136.00
+5.6% upside vs current
Range: $119.00 — $155.00
Altman Z
1.9
Piotroski
5/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

THRD buys
0
PLD buys
0
No recent congressional trades found for THRD or PLD in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricTHRDPLD
Forward yield37.17%3.18%
Annual dividend / share$2.00$4.10
Payout ratio50%50%
1-year div growth0%0%
5-year div CAGR0%74.4%
Portfolio after 10y$198.5K$6.50M
Annual income after 10y$31,557.09$5,256,436.18
Total dividends collected$146.1K$6.37M
Payment frequencyquarterlyquarterly
SectorStockREIT
Analyst consensusHoldBuy
Analyst price target$16.15$136.00

Year-by-year: THRD vs PLD ($10,000, DRIP)

YearTHRD PortfolioTHRD Income/yrPLD PortfolioPLD Income/yrGap
1$14,417$3,717.47$11,255$555.24+$3.2KTHRD
2$20,436$5,009.02$13,062$1,018.59+$7.4KTHRD
3$28,502$6,635.45$15,903$1,926.67+$12.6KTHRD
4$39,146$8,649.01$20,839$3,823.32+$18.3KTHRD
5$52,988$11,101.91$30,464$8,166.08+$22.5KTHRD
6$70,742$14,044.48$52,054$19,457.30+$18.7KTHRD
7← crossover$93,217$17,523.45$109,886$54,188.93$16.7KPLD
8$121,322$21,580.22$304,030$186,451.18$182.7KPLD
9$156,064$26,249.33$1,166,125$840,813.32$1.01MPLD
10$198,546$31,557.09$6,504,190$5,256,436.18$6.31MPLD

THRD vs PLD: Complete Analysis 2026

THRDStock

Third Harmonic Bio, Inc., a clinical-stage biopharmaceutical company, focuses on the development of the medicine for the treatment of allergic and inflammatory diseases. It develops THB001, an oral small-molecule KIT inhibitor for the treatment of chronic urticaria, a dermatologic disease driven by mast cell activation that results in red, itchy, painful welts, or hives, as well as for airway and gastrointestinal tract indications. The company was formerly known as Project IGE, Inc. and changed its name to Third Harmonic Bio, Inc. in June 2019. Third Harmonic Bio, Inc. was founded in 2019 and is headquartered in Cambridge, Massachusetts.

Full THRD Calculator →

PLDREIT

Prologis, Inc. is the global leader in logistics real estate with a focus on high-barrier, high-growth markets. As of December 31, 2020, the company owned or had investments in, on a wholly owned basis or through co-investment ventures, properties and development projects expected to total approximately 984 million square feet (91 million square meters) in 19 countries. Prologis leases modern logistics facilities to a diverse base of approximately 5,500 customers principally across two major categories: business-to-business and retail/online fulfillment.

Full PLD Calculator →
📬

Get this THRD vs PLD comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

THRD vs SCHDTHRD vs JEPITHRD vs OTHRD vs KOTHRD vs MAIN

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.